|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2025―Mar―31 |
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024 |
Louise M. Cremer, Jannik Stemler, Rosanne Sprute, Sebastian Herrmann, Theresa Markus, Jon Salmanton-García, Lutz Gieselmann, Veronica Di Cristanziano, Henning Gruell, Oliver A. Cornely, Sibylle C. Mellinghoff |
2 |
[GO] |
2023―Sep―27 |
ABO blood group and rhesus factor association with inpatient COVID-19 mortality and severity: a two-year retrospective review |
Alexander T. Phan, Ari A. Ucar, Aldin Malkoc, Janie Hu, Luke Buxton, Alan W. Tseng, Fanglong Dong, Julie P.T. Nguyễn, Arnav P. Modi, Ojas Deshpande, Johnson Lay, Andrew Ku, Dotun Ogunyemi, Sarkis Arabian |
3 |
[GO] |
2023―Jul―11 |
Investigating the prevalence of and predictive and risk factors for pulmonary embolism in patients with COVID-19 in Nemazee Teaching Hospital |
Mahnaz Yadollahi, Hessam Hosseinalipour, Mehrdad Karajizadeh, Muhammad Alinaqi, Pooria Fazeli, Mehrdad Jowkar, Kazem Jamali, Maryam Yadollahi |
4 |
[GO] |
2023―Jun―14 |
A case report of thrombotic thrombocytopenic purpura-like syndrome after Coronavirus disease 2019 vaccination |
Sua Noh, Sang A Kim, Ji Yun Lee, Jeong Ok Lee, Soo Mee Bang |
5 |
[GO] |
2023―May―10 |
Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection |
Alireza Sadeghi, Somayeh Sadeghi, Mohammad Saleh Peikar, Maryam Yazdi, Mehran Sharifi, Safie Ghafel, Farzin Khorvash, Behrooz Ataei, Mohammad Reza Safavi, Elahe Nasri |
6 |
[GO] |
2023―Feb―27 |
Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19? |
Nusa Matijasic Stjepovic, Izabela Kranjcec, Alenka Gagro, Gordana Jakovljevic |
7 |
[GO] |
2023―Feb―08 |
The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review |
Reham Osama Mansour, Shaimaa El-Ashwah, May Denewer |
8 |
[GO] |
2022―Dec―29 |
Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx |
Edel Mullen, Stephen Bergin, Geraldine Healy, John Quinn, Siobhan Glavey, Philip Thomas Murphy |
9 |
[GO] |
2022―Aug―03 |
Chest multidetector computed tomography imaging of COVID-19 pneumonia patients with hematologic malignancies |
Adel El-Badrawy, Nada Elbadrawy |
10 |
[GO] |
2022―Mar―28 |
COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia |
Chul Soo Kim, Jeong Yeon Kim, Dae Ro Choi |
11 |
[GO] |
2022―Mar―28 |
A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness |
Chul Soo Kim, Jae Gyu Kwak, Seongsoo Jang, Soo-Mee Bang |
12 |
[GO] |
2022―Feb―24 |
Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy |
Hebat- Allah Hasan Nashaat, Maha Anany, Fadia Moustafa Attia |
13 |
[GO] |
2021―Dec―09 |
The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19 |
Somayeh Sadeghi, Maryam Nasirian, Elaheh Keivany, Peiman Nasri, Maryam Mirenayat |
14 |
[GO] |
2021―Dec―09 |
Immune thrombocytopenic purpura worsened by COVID-19 |
Chul Soo Kim, Dae Ro Choi, Jong Hwa Lee |
15 |
[GO] |
2021―Nov―22 |
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19 |
Hee Ryeong Jang, Kyu-Hyoung Lim |
16 |
[GO] |
2021―Aug―31 |
Management of COVID-19-related immune thrombocytopenia by rhTPO |
Xuzhao Zhang, Min Li, Tao Chen, Dong Lv, Pengfei Xia, Wenbin Qian |
17 |
[GO] |
2021―Aug―17 |
Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy |
Karin Zattar Cecyn, Mariana Oliveira Marques, Milena Almendra Rodrigues, Fábio Nascimento Brito, Otávio Cesar Carvalho Guimarães Baiocchi |
18 |
[GO] |
2021―Aug―17 |
Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
Víctor Manuel Anguiano-Álvarez, José Antonio Maza-Larrea, Francisco Javier Rosado-Hernández, Gustavo Rojas-Velasco, Raúl Izaguirre-Ávila |
19 |
[GO] |
2021―Aug―05 |
Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19 |
Elpiniki Kritikou-Griva, Ioulia Chaliori, Nikolaos J. Tsagarakis, Georgios Androutsos, Sofia Chaniotaki, Georgios Paterakis |
20 |
[GO] |
2021―Jun―04 |
Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection |
Poojith Nuthalapati, Mohan Krishna Ghanta, Nagabhishek Sirpu Natesh, Bhaskar L.V.K.S. |
21 |
[GO] |
2021―May―14 |
Leukoerythroblastosis with dyserythropoiesis in an adolescent with SARS-CoV-2-associated macrophage activation syndrome |
Mahtab Fakhari, Jeremy M Loberger, Geling Li |
22 |
[GO] |
2021―Mar―12 |
COVID-19 pandemic: a double-edged sword for cord blood banking |
Young-Ho Lee |
23 |
[GO] |
2021―Feb―25 |
Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19 |
Hee Sue Park, Kyeong Seob Shin, Bo Ra Son |
24 |
[GO] |
2020―Dec―31 |
COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale |
Ankur Jain, Aditi Jain, Pooja Prasad, Sumita Chaudhry, Monica Sharma, Jitender Mohan Khunger, Dipender Kumar Gupta, Sumita Saluja |
25 |
[GO] |
2020―Nov―03 |
The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19) |
Bachti Alisjahbana, Ian Huang, Amaylia Oehadian |
26 |
[GO] |
2020―Nov―03 |
Pulmonary Embolism Rate in Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2 |
Kathleen M. Capaccione, Gen Li, Mary M. Salvatore |
27 |
[GO] |
2020―Jun―29 |
Coronavirus disease-19 and its hematological manifestations |
Hye-Ran Kim, Young-Eun Lee, Min-Gu Kang, Seung-Yeob Lee, Jun Hyung Lee, Myung-Geun Shin |